SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

EU Approves Extended Libtayo Dosing and Faster Infusions

The European Union approved extended dosing and faster infusion times for Libtayo (cemiplimab) across skin, lung and cervical cancer indications.

REGN

Related stories